Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Calnek BW, Hitchner SB. Highly potent, viable and stable cell-free virus preparations from cells infected with cell-associated viruses and method for obtaining the same. US Patent 3,783,098 dated Jan 1 1974
Eidson CS, Schmittle SC. Studies on acute Marek's disease. I. Characteristics of isolate GA in chickens. Avian Dis. 12: 467-476, 1968. PubMed: 4301071
Reddy SM, et al. Development of a quantitative-competitive polymerase chain reaction assay for serotype 1 Marek's disease virus. Avian Dis. 44: 770-775, 2000. PubMed: 11195630.
Silva RF. Differentiation of pathogenic and non-pathogenic serotype 1 Marek's disease viruses (MDVs) by the polymerase chain reaction amplification of the tandem direct repeats within the MDV genome. Avian Dis. 36: 521-528, 1992. PubMed: 1329706
Nucleotide (GenBank) : U63464 Gallid herpesvirus 2 DNA polymerase gene, partial cds.
